AI in drug discovery

R&D

The first era of AI in pharma was built on potential. This next era will be built on proof, reinforcing even greater potential.

News

AI-powered techbio firm Caris Life Sciences has raised the target price for its IPO, pointing to strong demand among investors.

News

AstraZeneca taps China's CSPC Pharma for new drug candidates a second time – and the latest AI-focused alliance is a big one.

News

Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI.

Digital

Using GPT can drastically increase the probability of success in the process of finding new molecules that can be used for drugs.

News

BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.